ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ImCheck Therapeutics SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11124
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer and other immune related diseases. It works in collaboration with institutions and academics to develop precision & personalized medicines. The company is a spin-off from Marseille’s Institut Paoli-Calmettes. ImCheck Therapeutics is headquartered in Marseille, France.

ImCheck Therapeutics SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImCheck Therapeutics SAS, Medical Devices Deals, 2012 to YTD 2018 9
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
ImCheck Therapeutics Raises USD21.8 Million in Series A Financing 11
Kurma Partners Invests in Imcheck Therapeutics 13
Licensing Agreements 14
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
Equity Offering 15
ImCheck Therapeutics Spin Out from Institut Paoli-Calmettes 15
ImCheck Therapeutics SAS – Key Competitors 16
ImCheck Therapeutics SAS – Key Employees 17
ImCheck Therapeutics SAS – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Sep 12, 2018: Imcheck Therapeutics appoints Prof. Rene Hoet, Phd, as Chief Scientific Officer 19
May 25, 2018: ImCheck Therapeutics Names Dr. Debasish Roychowdhury As Independent Board Chairman 20
May 02, 2017: ImCheck Therapeutics appoints its CEO 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Key Facts 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImCheck Therapeutics SAS, Deals By Therapy Area, 2012 to YTD 2018 8
ImCheck Therapeutics SAS, Medical Devices Deals, 2012 to YTD 2018 9
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImCheck Therapeutics Raises USD21.8 Million in Series A Financing 11
Kurma Partners Invests in Imcheck Therapeutics 13
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
ImCheck Therapeutics Spin Out from Institut Paoli-Calmettes 15
ImCheck Therapeutics SAS, Key Competitors 16
ImCheck Therapeutics SAS, Key Employees 17

List of Figures
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImCheck Therapeutics SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vaccinex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …
  • Lamb Weston Holdings, Inc. (LW):企業の財務・戦略的SWOT分析
    Lamb Weston Holdings, Inc. (LW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Qatar Electricity & Water Co QPSC (QEWS):企業の財務・戦略的SWOT分析
    Qatar Electricity & Water Co QPSC (QEWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • EDAP TMS SA (EDAP):医療機器:M&Aディール及び事業提携情報
    Summary EDAP TMS SA (EDAP) is a medical device company. It carries out the development, production and distribution of minimally invasive medical devices for the treatment of urological diseases. It offers High Intensity Focused Ultrasound (HIFU) devices for the treatment of localized prostate cance …
  • Vallourec SA:戦略・SWOT・企業財務分析
    Vallourec SA - Strategy, SWOT and Corporate Finance Report Summary Vallourec SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sumitomo Chemical Co Ltd (4005):企業の財務・戦略的SWOT分析
    Sumitomo Chemical Co Ltd (4005) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Glythera Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Glythera Ltd (Glythera) is a biotechnology company that focuses on the development of antibody drug conjugates (ADCs) and biotherapeutics for the treatment of cancer. The company develops antibody-based therapies for the treatment of cancer and broader based therapeutics. It uses its proprie …
  • X4 Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary X4 Pharmaceuticals Inc (X4 Pharma) is a clinical stage biotechnology company that develops novel therapeutics to treat cancer and rare diseases. The company’s lead drug candidate, X4P-001-LD, is in Phase 2/3 trial used for the treatment for patients with WHIM and other immunodeficiencies. It …
  • Laboratorios Liomont SA de CV:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios Liomont SA de CV (Liomont) is a pharmaceutical company that develops medication products. The company offers prescription medication products, biotech products and over the counter products. It provides drugs in various therapeutic areas including analgesics, antiparasitic, anti …
  • Alfresa Holdings Corporation:企業の戦略・SWOT・財務情報
    Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lario Oil & Gas Company:石油・ガス:M&Aディール及び事業提携情報
    Summary Lario Oil & Gas Company (Lario Oil & Gas) is an oil and gas exploration and production company that explores and produces oil and gas properties. The company offers services such as discovering reserves organically from geologic thesis, drill-bit, field delineation, and land acquisition and …
  • Transportadora de Gas del Sur S.A.:企業の戦略・SWOT・財務情報
    Transportadora de Gas del Sur S.A. - Strategy, SWOT and Corporate Finance Report Summary Transportadora de Gas del Sur S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • KBR Inc (KBR):企業の財務・戦略的SWOT分析
    KBR Inc (KBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • First Light Biosciences Inc:企業の製品パイプライン分析2018
    Summary First Light Biosciences Inc (FLB) is a medical device company that develops and manufactures automated medical diagnostic products for the detection of healthcare associated infections. The company’s product includes multipath analyzer system. Its multipath analyzer system detects resistant …
  • Codan Radio Communications:企業の戦略・SWOT・財務情報
    Codan Radio Communications - Strategy, SWOT and Corporate Finance Report Summary Codan Radio Communications - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The Cooper Companies Inc (COO):企業の財務・戦略的SWOT分析
    The Cooper Companies Inc (COO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Prothena Corp Plc (PRTA)-医療機器分野:企業M&A・提携分析
    Summary Prothena Corp Plc (Prothena) is a biotechnology company that discovers, develops and markets novel antibodies that are indicated for the treatment of diseases associated with amyloid or cell adhesion. The company develops monoclonal antibodies directed specifically at disease-causing protein …
  • Tessi S.A. (TES):企業の財務・戦略的SWOT分析
    Tessi S.A. (TES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Slovenske elektrarne, a.s.:発電所・企業SWOT分析
    Slovenske elektrarne, a.s. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Ambu AS (AMBU B):企業の財務・戦略的SWOT分析
    Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆